Information  X 
Enter a valid email address

Tiziana Life Sci PLC (TILS)

  Print      Mail a friend

Tuesday 21 August, 2018

Tiziana Life Sci PLC

PDMR dealings

RNS Number : 3549Y
Tiziana Life Sciences PLC
21 August 2018
 

Tiziana Life Sciences plc

(Incorporated in England and Wales with company number 09665181)

PDMR dealings

 

Tiziana Life Sciences plc (LSE: TILS) (the "Company") announces that on 20 August 2018, Dr Shailubhai Kunwar, Chief Executive Officer and Tiziano Lazzaretti, Chief Financial Officer bought  shares in the Company as follows :

The information set out below is provided in accordance with the requirements of Regulation 19(3) of the EU Market Abuse Regulation No 596/2014:

 

1.

Details  of PDMR / person closely associated

a)

Name

Dr Shailubhai Kunwar

2.

Reason for the notification: On market acquisition

a)

Position / status

Chief Executive Officer

b)

Initial notification /amendment

Initial notification

3.

Details of the issuer

a)

Name

Tiziana Life Sciences plc

b)

LEI

213800CED47HI8PIOB36

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type  of transaction; (iii) each date; and (iv) each place where transactions have  been conducted

a)

Description of the financial instrument

Ordinary Shares of 3p each

b)

Identification code of the Financial Instrument

ISIN for Tiziana Life Sciences plc: GB00BKWNZY55

c)

Nature of the transaction

Acquisition of shares  

d)

Price(s) and volume(s)



Price: £1.01; Volume: 5,000

e)

Aggregated information

-     Aggregated volume

-     Price

 

5,000

 £5,050

 

 

f)

Date of the transaction

20 August 2018

g)

Place of the transaction

XLON  

 

1.

Details  of PDMR / person closely associated

a)

Name

Tiziano Lazzaretti

2.

Reason for the notification: On market acquisition

a)

Position / status

Chief Financial Officer

b)

Initial notification /amendment

Initial notification

3.

Details of the issuer

a)

Name

Tiziana Life Sciences plc

b)

LEI

213800CED47HI8PIOB36

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type  of transaction; (iii) each date; and (iv) each place where transactions have  been conducted

a)

Description of the financial instrument

Ordinary Shares of 3p each

b)

Identification code of the Financial Instrument

ISIN for Tiziana Life Sciences plc: GB00BKWNZY55

c)

Nature of the transaction

Acquisition of shares  

d)

Price(s) and volume(s)



Price: £0.80; Volume: 2,000

e)

Aggregated information

-     Aggregated volume

-     Price

 

2,000

 £1,625

 

 

f)

Date of the transaction

20 August 2018

g)

Place of the transaction

XLON  

 

Neither Dr Shailubhai nor Mr Lazzaretti were holders of shares in the Company prior to the acquisitions set out above.

For more information go to http://www.tizianalifesciences.com

 

Contacts:

 

Tiziana Life Sciences plc

Gabriele Cerrone, Chairman and founder

 

 

 

+44 (0)20 7493 2853

Cairn Financial Advisers LLP (Nominated adviser)

Liam Murray / Jo Turner

+44 (0)20 7213 0883

Stockdale Securities (Broker)

Antonio Bossi / Andy Crossley

 

+44 (0)20 7601 6100

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHDBLFLVVFXBBV

a d v e r t i s e m e n t